Financials

  • Market Capitalization 20.94 M
  • Employee 18
  • Founded 2020
  • CEO N/A
  • Website www.tevogen.com
  • Headquarter Delaware, United States
  • FIGI BBG013395405
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.05
Relación precio/flujo de caja
-280.95

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4593
CELU
Celularity Inc. - Class A Common Stock
0.76 USD+2.70%0.00%-5.00%-68.60%22.00 M USD
4604
CLRB
Cellectar Biosciences, Inc. - Common Stock
2.63 USD-6.74%-6.07%+14.35%-16.24%21.02 M USD
4611
ATOS
Atossa Therapeutics, Inc. - Common Stock
2.40 USD+1.27%+1.27%-4.38%+155.32%20.67 M USD
4620
KALA
KALA BIO, Inc. - Common Stock
1.09 USD-7.63%-27.81%-59.33%-81.21%20.26 M USD

Noticias